Defibrotide Sodium API Suppliers & Bulk Manufacturers
Available Forms: API (drug substance)
Available Strengths: Supplied to an in-house or pharmacopoeial specification
Reference Brands: Defitelio
Category: Active Pharmaceutical Ingredient
Defibrotide sodium is a mixture of oligonucleotides derived from porcine intestinal DNA, used in an injection for hepatic veno-occlusive disease. Specialist injectable makers and R&D teams source it.
Manufacture or export Defibrotide Sodium API? List it or send an offer →
Product Description:
Defibrotide is a mixture of mostly single-stranded oligodeoxyribonucleotides with profibrinolytic properties, helping to restore the balance between clot formation and breakdown in the small blood vessels of the liver. It is approved for adults and children with hepatic veno-occlusive disease, also called sinusoidal obstruction syndrome, after haematopoietic stem-cell transplantation; the US label covers cases with renal or pulmonary dysfunction and the EU label covers severe disease (reference brand: Defitelio).
Specification at a glance
| Traded form | Sodium salts of polydeoxyribonucleotides derived from porcine intestinal tissue; potency is expressed in biological units |
|---|---|
| CAS number | 83712-60-1 |
| Molecular weight | Polydisperse; mean weighted molecular weight 13–20 kDa (US label) |
| Pharmacopoeia | No pharmacopoeia monograph found (unverified); supplied to an in-house specification that includes potency by biological assay. |
Regulatory files and timing
The FDA list of Drug Master Files (third quarter 2026) shows 0 active Type II API DMFs for this molecule. Few filings usually means few qualified sources, so early contact with suppliers pays off. For Europe, ask whether the supplier holds a CEP or an EU ASMF and, for imports into the EU, a written confirmation.
Generic or biosimilar entry. United States: Patent expiry; entry not confirmed (to 2032 (non-compound patents)). European Union: No confirmed date.
Handling and quality points
As an animal-derived substance, defibrotide needs full traceability of the porcine source, viral safety and TSE documentation, and a clear description of the extraction and depolymerisation process. Quality rests on more than chemical purity: molecular weight distribution, chain composition and biological potency all need to match the reference product, so ask how each is measured. It goes into an injectable, so bioburden, endotoxin and the supplier's controls on microbial quality matter.
Send an API enquiry All specialty APIs
Brand names are trademarks of their respective owners and identify the reference medicine only. Information is general and was checked in October 2026; confirm specifications and filings with the supplier before purchase.
Defibrotide Sodium API — third party manufacturing & bulk supply
Defibrotide Sodium API is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Defibrotide Sodium API is supplied as API (drug substance) — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Defibrotide Sodium API listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Defibrotide Sodium API →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Alongside the GMP certificate and certificate of analysis, buyers ask for animal-origin documentation: source species and country, veterinary health certificates and a TSE statement. Viral inactivation or clearance data, endotoxin and bioburden results, stability data and a DMF or ASMF reference, where one exists, are also standard requests.
It is a heterogeneous mixture rather than a single structure, so sameness has to be shown through molecular weight profile, chain composition and activity in biological assays. Regulators will expect detailed physicochemical and biological comparison with the reference product.
Yes. We match licensed injectable manufacturers, CDMOs and research groups with GMP-compliant producers of complex APIs such as defibrotide, after a first check of their documents. Your details remain private until both sides choose to go ahead.
Related Products
Midostaurin API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Rydapt
View DetailsSiponimod API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Mayzent
View DetailsPlecanatide API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Trulance
View DetailsPasireotide API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Signifor, Signifor LAR
View DetailsElagolix Sodium API
Strength:
USP grade or in-house specification
Form: API (drug substance)
Reference Brands: Orilissa, Oriahnn
View DetailsRilpivirine Hydrochloride API
Strength:
USP grade or in-house specification
Form: API (drug substance)
Reference Brands: Edurant, Complera, Odefsey, Juluca
View DetailsBrentuximab Vedotin Drug Substance
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: Drug substance (bulk)
Reference Brands: Adcetris
View DetailsRomiplostim Drug Substance
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: Drug substance (bulk)
Reference Brands: Nplate
View DetailsUsually answered within 48 hours | GMP documents shared before you commit